Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - NetInterest Income - TotalInterest income - InvestmentsInterest income - LoansInvestment Banking IncomeNet Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOperating IncomeOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRestructuring CostsRevenueTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Alerus Financial (ALRS) Research & Development (2018 - 2025)

Historic Research & Development for Alerus Financial (ALRS) over the last 8 years, with Q3 2025 value amounting to $1.1 million.

  • Alerus Financial's Research & Development rose 3992.15% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 2951.81%. This contributed to the annual value of $3.2 million for FY2024, which is 733.4% up from last year.
  • As of Q3 2025, Alerus Financial's Research & Development stood at $1.1 million, which was up 3992.15% from $787000.0 recorded in Q2 2025.
  • In the past 5 years, Alerus Financial's Research & Development ranged from a high of $1.1 million in Q3 2025 and a low of $600000.0 during Q1 2022
  • Moreover, its 5-year median value for Research & Development was $787000.0 (2025), whereas its average is $815315.8.
  • In the last 5 years, Alerus Financial's Research & Development tumbled by 1830.47% in 2023 and then skyrocketed by 4087.59% in 2025.
  • Alerus Financial's Research & Development (Quarter) stood at $872000.0 in 2021, then rose by 19.95% to $1.0 million in 2022, then dropped by 15.11% to $888000.0 in 2023, then grew by 18.13% to $1.0 million in 2024, then increased by 1.91% to $1.1 million in 2025.
  • Its Research & Development stands at $1.1 million for Q3 2025, versus $787000.0 for Q2 2025 and $965000.0 for Q1 2025.